This week, a breakthrough for heart failure patients with mitral regurgitation emerges, prosthesis-patient mismatch raises the risk of death following TAVR, a new study challenges anticoagulation guidelines, and a possible blessing in disguise for rivaroxaban comes from the massive COMPASS trial. Subscribe to Cardiocast wherever you get your podcasts. Amazon Alexa Apple Podcasts

The MDedge cardiology team is back for the second edition of their debrief on the 2018 annual congress of the European Society of Cardiology. The team includes MDedge editor Catherine Hackett and MDedge reporters Bruce Jancin and Mitchel Zoler.

Radiation from coronary CT angiography plummeted in the past decade. Also this week, hospital stays for endocarditis patients are cut in half with a new protocol, children born from assisted reproductive technologies may be prone to cardiovascular problems, and elderly patients only benefit from statins if they have diabetes.

A new definition in myocardial infarction. Also today, aspirin and fish oil flap in patients with diabetes, CT angiography cuts MI in patients with stable chest pain, and rivaroxaban is no help for heart failure outcomes.

The MDedge Cardiology team unpacks one of the world’s largest cardiology meetings from a Munich beer garden. Join MDedge reporters Bruce Jancin and Mitchel Zoler alongside MDedge Cardiology editor Catherine Hacket as they discuss practice-changing data as well as what the world’s leading cardiologists are talking about. Some of the stories discussed in this episode are:

ASCEND: Aspirin, fish oil flop in diabetes

Rivaroxaban no help for heart failure outcomes

Rivaroxaban superior to aspirin for extended VTE treatment

New data from an observational study show that breastfeeding was linked with a lower risk of stroke later in life. Also today, a new Valsalva maneuver is tops at converting supraventricular tachycardia to sinus rhythm, and a warning about the growing occurrence of finding about a key component of some artificial hearts

Breast artery calcification, evident on every mammogram, may help refine coronary artery disease risk in women. Also this week, new guidelines reclassify adult congenital heart disease, advice to eat a variety of foods seems to have backfired, and how PCI can now safely tackle complex chronic total occlusions.

Cardiologists in states with payment limits for medical malpractice claims practice less defensive medicine. Also this week, Herceptin is linked to doubling heart failure risk in women with breast cancer, Sapien 3 performs mostly well in bicuspid aortic stenosis, and PhRMA leads the way in healthcare lobbying.

Female authorship in cardiology journals has increased over the last 20 years. However, it still lags behind other specialties and academic medicine overall. Also this week, valsartan recall and risk, synergy DES shines in acute MI, and incident heart failure is linked to HIV infection.

Hypertension meds slashed mild cognitive impairment risk by 19% in the SPRINT MIND study. Are omega-3 fatty acids' heart benefits just another fish tale? Early antidepressant therapy after a heart attack delivers benefits years later. And new guidelines say PFO closure is the best way to prevent recurrent stroke.